Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544335 · ClinicalTrials.gov registry record
Evaluation of BIS for Quantification of Lymphedema
A clinical trial of Breast Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 270
- Enrollment target
- 1
- Study location
NCT01544335: Completed study of Breast Cancer, sponsored by Massachusetts General Hospital.
NCT01544335 is a study of Breast Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 270 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01544335, a study of Breast Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether measuring the fluid in your arms using Bioimpedance Spectroscopy is as effective at detecting and monitoring lymphedema as measurements with the Perometer. The investigators will also evaluate any symptoms you may experience in your arms during and after treatment for breast cancer with a questionnaire.
Conditions Studied
Interventions
- OTHER Bioimpedance Spectroscopy
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2011-12 |
| Est. Completion | 2020-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01544335
The ClinicalTrials.gov registry entry for NCT01544335 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Bioimpedance Spectroscopy is the first listed.
NCT01544335 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01544335 about?
NCT01544335 is a clinical study titled "Evaluation of BIS for Quantification of Lymphedema". The purpose of this study is to determine whether measuring the fluid in your arms using Bioimpedance Spectroscopy is as effective at detecting and monitoring lymphedema as measurements with the Perometer. The investigators will also evaluate any symptoms you may experience in your arms during and a...
What is the current status of trial NCT01544335?
This trial is currently completed. The enrollment target is 270 participants. The study started on 2011-12. Estimated completion is 2020-09.
What conditions does trial NCT01544335 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01544335?
The interventions under investigation include: Bioimpedance Spectroscopy (OTHER).
Who is sponsoring clinical trial NCT01544335?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01544335 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.